ArticleBritish journal of cancer2023

Biparatopic anti-HER2 drug radioconjugates as breast cancer theranostics.

Jessica Pougoue Ketchemen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.